These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8510026)

  • 1. Intrinsic properties of the nonpeptide angiotensin II antagonist losartan in glomeruli and mesangial cells at high concentrations.
    Chansel D; Badre L; Czekalski S; Vandermeersch S; Cambar J; Ardaillou R
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1534-43. PubMed ID: 8510026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of angiotensin II and losartan binding sites in glomeruli and mesangial cells.
    Chansel D; Bizet T; Vandermeersch S; Pham P; Levy B; Ardaillou R
    Am J Physiol; 1994 Mar; 266(3 Pt 2):F384-93. PubMed ID: 8160786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo pharmacological characterization of UP 269-6, a novel nonpeptide angiotensin II receptor antagonist.
    Cazes M; Provost D; Versigny A; Cloarec A
    Eur J Pharmacol; 1995 Sep; 284(1-2):157-70. PubMed ID: 8549620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
    Shibouta Y; Inada Y; Ojima M; Wada T; Noda M; Sanada T; Kubo K; Kohara Y; Naka T; Nishikawa K
    J Pharmacol Exp Ther; 1993 Jul; 266(1):114-20. PubMed ID: 8331552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent.
    Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
    J Pharmacol Exp Ther; 1990 Oct; 255(1):211-7. PubMed ID: 2213556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the inhibitory effects of DuP 753 and EXP 3174 on responses to angiotensin II in the feline hindquarters vascular bed.
    Osei SY; Minkes RK; Bellan JA; Kadowitz PJ
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1104-12. PubMed ID: 8450454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydropyrimidine angiotensin II receptor antagonists.
    Atwal KS; Ahmed SZ; Bird JE; Delaney CL; Dickinson KE; Ferrara FN; Hedberg A; Miller AV; Moreland S; O'Reilly BC
    J Med Chem; 1992 Dec; 35(25):4751-63. PubMed ID: 1469703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Losartan inhibits the angiotensin II-induced stimulation of the phosphoinositide signalling system in vascular smooth muscle cells.
    Ko Y; Görg A; Appenheimer M; Wieczorek AJ; Düsing R; Vetter H; Sachinidis A
    Eur J Pharmacol; 1992 Oct; 227(2):215-9. PubMed ID: 1426030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies.
    Wienen W; Mauz AB; Van Meel JC; Entzeroth M
    Mol Pharmacol; 1992 Jun; 41(6):1081-8. PubMed ID: 1614410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H- benzimidazole-7-carboxylate (TCV-116), in various hypertensive rats.
    Inada Y; Wada T; Shibouta Y; Ojima M; Sanada T; Ohtsuki K; Itoh K; Kubo K; Kohara Y; Naka T
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1540-7. PubMed ID: 8138966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II-induced responses in vascular smooth muscle cells: inhibition by non-peptide receptor antagonists.
    Catalioto RM; Porchia R; Renzetti AR; Criscuoli M; Subissi A; Giachetti A
    Eur J Pharmacol; 1995 Jul; 280(3):285-92. PubMed ID: 8566096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of angiotensin IV and angiotensin-(1-7) on basal and angiotensin II-stimulated cytosolic Ca2+ in mesangial cells.
    Chansel D; Vandermeersch S; Oko A; Curat C; Ardaillou R
    Eur J Pharmacol; 2001 Mar; 414(2-3):165-75. PubMed ID: 11239916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.
    Siegl PK; Chang RS; Mantlo NB; Chakravarty PK; Ondeyka DL; Greenlee WJ; Patchett AA; Sweet CS; Lotti VJ
    J Pharmacol Exp Ther; 1992 Jul; 262(1):139-44. PubMed ID: 1625193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II requires PDGF-BB to induce DNA synthesis in rat mesangial cells cultured in an exogenous insulin-free medium.
    Higueruelo S; Romero R
    Nephrol Dial Transplant; 1997 Apr; 12(4):694-700. PubMed ID: 9140996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent.
    Chiu AT; McCall DE; Price WA; Wong PC; Carini DJ; Duncia JV; Wexler RR; Yoo SE; Johnson AL; Timmermans PB
    J Pharmacol Exp Ther; 1990 Feb; 252(2):711-8. PubMed ID: 2313596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial natriuretic peptide inhibits angiotensin II-induced contraction of isolated glomeruli and cultured glomerular mesangial cells of rats: the role of calcium.
    de Arriba G; Barrio V; Olivera A; Rodriguez-Puyol D; López-Novoa JM
    J Lab Clin Med; 1988 Apr; 111(4):466-74. PubMed ID: 2965193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glomerular effects of angiotensin II: a reappraisal based on studies with non-peptide receptor antagonists.
    Ardaillou R; Chansel D
    J Hypertens Suppl; 1993 Apr; 11(3):S43-7. PubMed ID: 8315519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the specific angiotensin II receptor antagonist losartan on urate homeostasis and intestinal urate transport.
    Hatch M; Freel RW; Shahinfar S; Vaziri ND
    J Pharmacol Exp Ther; 1996 Jan; 276(1):187-93. PubMed ID: 8558429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between angiotensin II and norepinephrine on renin release by juxtaglomerular cells.
    Ichihara A; Suzuki H; Murakami M; Naitoh M; Matsumoto A; Saruta T
    Eur J Endocrinol; 1995 Nov; 133(5):569-77. PubMed ID: 7581987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nonpeptide angiotensin II antagonists].
    Shionoiri H; Takasaki I; Sugimoto K; Minamisawa K
    Nihon Rinsho; 1992 Apr; 50 Suppl():753-63. PubMed ID: 1635263
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.